Works matching DE "ERLOTINIB"

Results: 1027
    1

    Antitumor efficacy of intermittent low‐dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche.

    Published in:
    International Journal of Cancer, 2025, v. 157, n. 2, p. 355, doi. 10.1002/ijc.35409
    By:
    • Tripathi, Chakrapani;
    • Tovar Perez, Jorge E.;
    • Kapoor, Sabeeta;
    • Muhsin, Ahmed;
    • Dashwood, Wan Mohaiza;
    • Demirhan, Yunus;
    • Demirhan, Melek;
    • Shapiro, Alessandro;
    • Mohammed, Altaf;
    • Sei, Shizuko;
    • Thompson, Jacklyn;
    • Zaheer, Mahira;
    • Sinha, Krishna M.;
    • Brown, Powel H.;
    • Savage, Michelle I.;
    • Vilar, Eduardo;
    • Rajendran, Praveen;
    • Dashwood, Roderick H.
    Publication type:
    Article
    2
    3

    Coca-Cola for Lung Cancer?

    Published in:
    RT: The Journal for Respiratory Care Practitioners, 2016, v. 29, n. 3, p. 34
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Cu‐Catalyzed Synthesis of 4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐4‐ones: Molecular Docking Studies and Anti‐Proliferative Activities Against HepG2 Hepatocellular Carcinoma Cells.

    Published in:
    Asian Journal of Organic Chemistry, 2024, v. 13, n. 6, p. 1, doi. 10.1002/ajoc.202400065
    By:
    • Aljaar, Nayyef;
    • Aboalrub, Husam F.;
    • Shtaiwi, Majed;
    • Sarhan, Ayman H. Abu;
    • Younes, Eyad A.;
    • Al‐Noaimi, Mousa;
    • Shtaiwi, Amneh;
    • Tahtamouni, Lubna H.;
    • Abu‐Safieh, Kayed A.;
    • AlObaid, Abeer A.;
    • Malakar, Chandi C.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells.

    Published in:
    Cancer Research & Treatment, 2021, v. 53, n. 2, p. 457, doi. 10.4143/crt.2020.585
    By:
    • Boonsri, Boonyakorn;
    • Yacqub-Usman, Kiren;
    • Thintharua, Pakpoom;
    • Kyaw Zwar Myint;
    • Sae-Lao, Thannicha;
    • Collier, Pam;
    • Suriyonplengsaeng, Chinnawut;
    • Larbcharoensub, Noppadol;
    • Balasubramanian, Brinda;
    • Venkatraman, Simran;
    • Egbuniwe, Isioma U.;
    • Gomez, Dhanwant;
    • Mukherjee, Abhik;
    • Kumkate, Supeecha;
    • Janvilisri, Tavan;
    • Zaitoun, Abed M.;
    • Kuakpaetoon, Thiti;
    • Tohtong, Rutaiwan;
    • Grabowska, Anna M.;
    • Bates, David O.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines.

    Published in:
    Cancers, 2024, v. 16, n. 13, p. 2490, doi. 10.3390/cancers16132490
    By:
    • Perez-Medina, Mario;
    • Lopez-Gonzalez, Jose S.;
    • Benito-Lopez, Jesus J.;
    • Ávila-Ríos, Santiago;
    • Soto-Nava, Maribel;
    • Matias-Florentino, Margarita;
    • Méndez-Tenorio, Alfonso;
    • Galicia-Velasco, Miriam;
    • Chavez-Dominguez, Rodolfo;
    • Meza-Toledo, Sergio E.;
    • Aguilar-Cazares, Dolores
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50